Nicotinamide modulates gut microbial metabolic potential and accelerates recovery in mild-to-moderate COVID-19
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research suggests that nicotinamide, a form of vitamin B3, may have a role in treating covid-19 by modulating the gut microbiome. A clinical trial has reportedly found that it can accelerate recovery in mild-to-moderate cases. The therapeutic potential of related compounds is also being explored in other areas, including obesity and neurodegenerative diseases.
Full coverage
1234